Q4 2014 Holdings
Filed 2015-02-17 | 14 holdings | $254.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medivation, Inc. | COM | 58501N101 | $221.6K | 2,244,519 | 87.2% |
| Ampio Pharmaceuticals Inc. | COM | 03209T109 | $11.6K | 3,388,322 | 4.6% |
| Synthetic Biologics Inc. | COM | 87164U102 | $5.0K | 3,400,816 | 2.0% |
| Alcobra Ltd | SHS | M2239P109 | $3.2K | 865,315 | 1.3% |
| Newlink Genetics Corp | COM | 651511107 | $3.1K | 77,437 | 1.2% |
| Keryx Biopharmaceuticals Inc. | COM | 492515101 | $2.8K | 200,000 | 1.1% |
| Bio Blast Pharma Ltd | SHS | M20156101 | $2.2K | 338,110 | 0.9% |
| Advaxis Inc. | COM NEW | 7624208 | $1.8K | 225,000 | 0.7% |
| Auspex Pharmaceuticals Inc. | COM | 05211J102 | $1.1K | 20,000 | 0.4% |
| Inovio Pharmaceuticals Inc. | COM NEW | 45773H201 | $754 | 82,088 | 0.3% |
| Advaxis Inc. | W EXP 07/15/201 | 7624117 | $467 | 112,500 | 0.2% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $377 | 65,000 | 0.1% |
| Provectus Biopharmaceuticals(PVCT) | COM | 74373P108 | $160 | 200,000 | 0.1% |
| Nephrogenex Inc | COM | 640667101 | $41 | 3,072 | 0.0% |